The UK Diabetes Devices Market is expected to witness growth from $591 Mn in 2022 to $887 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market is segmented by type and by the end user. Some key players in this market include Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.
The UK Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-30. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. The market is segmented by type and by gender. Some key players in this market include Renishaw, LivaNova, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Thailand Biomaterials Healthcare Market is expected to witness growth from $188 Mn in 2022 to $518 Mn in 2030 with a CAGR of 13.54% for the forecasted year 2022-30. Geriatric population and a rise in medical problems, there is a rising demand for biomaterials in Thailand. The market is segmented by type and by application. Some key players in this market include Biomed, Meticuly, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Tanzania's Coronary Stents Market is expected to witness growth from $5 Mn in 2022 to $7 Mn in 2030 with a CAGR of 5.65% for the forecasted year 2022-30. The Tanzanian government has been spending money to upgrade the nation's healthcare system, which includes building more hospitals and clinics. With increased access to medical institutions, especially those performing coronary stent treatments, this investment is likely to spur market expansion. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.
Sweden's Neurology Devices Market size was valued at $45 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Mn in 2030. The market for neurology devices in Sweden is expanding as a result of rising healthcare spending, population growth, ageing, and the rising demand for healthcare services are some of the variables that are responsible for this increase in spending. The market is segmented by product type and by the end user. Some key players in the market include Medtronic, Stryker, Abbott Laboratories, B. Braun Melsungen AG, Abbott Laboratories, Johnson and Johnson, and Jude Medical.
Spain's 3D printing medical devices market size was valued at $57 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.3% from 2022-30 and will reach $179 Mn in 2030. The market is segmented by component, application, technology, and end user. This market will grow medical devices manufactured to order using 3D printing providing new opportunities for improving patient care and creating ground-breaking treatments. The key market players are BCN3D Technologies (ESP), Regemat3D (ESP), EMO3D (ESP), Intamsys (ESP), Nanofabrica (ESP), Grupo Sicnova (ESP), Microlay (ESP), Zerintia Technologies (ESP), Mimetis Biomaterials (ESP), 3D Surgical Technologies (ESP), Dental Global Service (ESP), and others.
South Africa's contraceptive devices market is expected to from $84 Mn in 2022 to $170 Mn in 2030 with a CAGR of 9.23% for the forecasted year 2022-30. The huge young population in South Africa is fueling demand for more inventive and adaptable contraceptive methods that may accommodate their changing wants and lifestyles. The market is segmented by type and by gender. Some key players in this market include Gabler Medical, Sinapi Biomedical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer and Teva Pharmaceutical.
This report presents a strategic analysis of the Nigeria Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Nigeria Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
Nigeria's Diabetes Devices Market is expected to witness growth from $20 Mn in 2022 to $38 Mn in 2030 with a CAGR of 8.20 % for the forecasted year 2022-30. There is probably going to be more of a demand for diabetes devices in Nigeria as people look for better ways to manage their condition as knowledge of diabetes and its management increases. The market is segmented by type and by the end user. Some key players in this market include JNC International, GBioMed Nigeria, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
This report presents a strategic analysis of the Netherlands Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Netherlands Medical Devices Market, offering unmatched value, accuracy and expert insights.
Malaysia Biomaterials in Healthcare Market is expected to witness growth from $251 Mn in 2022 to $687 Mn in 2030 with a CAGR of 13.40% for the forecasted year 2022-30. Malaysia is seeing an increase in demand for cosmetic and plastic surgery due to growing disposable incomes and the availability of reasonably priced, high-quality healthcare services. Because biomaterials are frequently used in these procedures, manufacturers have chances to supply the market. The market is segmented by type and by application. Some key players in this market include Bioalpha Holdings Berhad, Biocon Sdn Bhd, Hovid Berhad, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
This report presents a strategic analysis of the Lebanon Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Lebanon Medical Devices Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Kenya Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Kenya Medical Devices Market, offering unmatched value, accuracy and expert insights.
Kenya's Cardiac Surgery Instruments Market is expected to witness growth from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-30. The market for cardiac surgery instruments is expanding in Kenya as there is a rising demand for minimally invasive treatments. The market is segmented by type, application and by the end user. Some key players in this market include Apicalmed, Asterisk, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Egypt ECG Equipment Market is expected to witness growth from $25 Mn in 2022 to $49 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-30. The Egyptian government has made significant investments in the healthcare industry, including the construction of brand-new hospitals and centres as well as the remodelling of already-existing ones. As a result, the demand for ECG equipment has grown. The market is segmented by product type and by the end user. Some key players in this market include Wassenburg Medical, EMG-EP Technologies, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.
This report presents a strategic analysis of the Canada Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Medical Devices Market, offering unmatched value, accuracy and expert insights.
The Ecuador Neurology Device Market is expected to witness growth from $xx Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The prevalence of neurological illnesses in Ecuador is increasing the demand for neurology devices. This encompasses conditions like stroke, Parkinson's disease, seizures, and multiple sclerosis, among others. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
Brazil's Coronary Stents Market is expected to grow from $283 Mn in 2022 to $442 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. Brazil has high rates of CAD incidence and prevalence, which raises serious public health concerns. As a result, there is an increasing need for coronary stents as a CAD treatment option, which is propelling market expansion. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
This report presents a strategic analysis of the Algeria Diabetes Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Algeria Diabetes Devices Market, offering unmatched value, accuracy and expert insights.
South Africa's Diabetes Devices Market is expected to grow from $148 Mn in 2022 to $282 Mn in 2030 with a CAGR of 8.43% for the forecasted year 2022-30. Diabetes is a severe health issue in South Africa, affecting 9.2% of the adult population. To meet the rising demand for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Gabler Medical, MediQ SHS, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Singapore ECG Equipment Market is expected to witness growth from $11 Mn in 2022 to $20 Mn in 2030 with a CAGR of 7.90% for the forecasted year 2022-30. The convenience, usability, and portability of portable and wireless ECG devices are driving up demand in Singapore. With the help of this equipment, patients may keep an eye on their heart health at home and send the information to clinicians for evaluation and therapy. It is anticipated that this tendency would increase demand for the producers of ECG equipment that provide such devices. The market is segmented by product type and by the end user. Some key players in this market include Biosensors International, Inzign Pte, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Qatar Neurology Devices Market size was valued at $50 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The Qatar Neurology devices market is expected to increase due to the country's ageing population. The prevalence of neurological conditions in the elderly, including stroke, dementia, and Parkinson's disease, will drive up demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Tech Q, Al-Sahel Medical, Medtronic, Johnson and Johnson, Boston Scientific, Stryker and GE Healthcare.
The Philippines Diabetes Devices Market is expected to witness growth from $50 Mn in 2022 to $91 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-30. Over 5 million adults in the Philippines have been diagnosed with diabetes, making it one of the most common illnesses in the globe. There is a rising need for diabetes devices in the Philippines to manage the disease as the prevalence of diabetes keeps rising in the Philippines. The market is segmented by type and by the end user. Some key players in this market include SpectruMed, RG Meditron, S.E.A. Olympus, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
The Philippines Biomaterials in Healthcare Market is expected to witness growth from $344 Mn in 2022 to $960 Mn in 2030 with a CAGR of 13.70% for the forecasted year 2022-30. In the Philippines, the prevalence of chronic diseases is on the rise, the population is ageing, and the medical tourism industry is expanding. These factors are some of the main market expansion drivers for manufacturers of the Biomaterials Healthcare market. The market is segmented by type and by application. Some key players in this market include SpectruMed, Getz Healthcare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
India's Coronary Stents Market is expected to grow from $206 Mn in 2022 to $373 Mn in 2030 with a CAGR of 7.75% for the forecasted year 2022-30. The need for coronary stents is being driven by a rising rate of heart disease in India. The prevalence of CAD is rising in India as a result of the rising incidence of risk factors such as diabetes, hypertension, and obesity. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include GPC Medical, Becton Dickinson, Sahajanand Medical Technologies, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.